Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Sorrento Therapeutics, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2027 | $761.59M | $761.59M - $761.59M | -$761.59M | $0.67 | 1 |
| Dec 2026 | $591.41M | $591.41M - $591.41M | -$591.41M | $0.44 | 1 |
| Dec 2025 | $382.71M | $382.71M - $382.71M | -$382.71M | $0.08 | 1 |
| Dec 2024 | $185.75M | $185.75M - $185.75M | -$185.75M | -$0.33 | 1 |
| Dec 2023 | $24.66M | $10.56M - $38.74M | -$461.08M | -$0.80 | 2 |
| Dec 2022 | $42.24M | $42.24M - $42.24M | -$375.01M | -$1.05 | 1 |
| Dec 2021 | $52.90M | $52.90M - $52.90M | -$325.45M | -$1.45 | 1 |
| Dec 2020 | $1.04B | $1.04B - $1.04B | -$256.04M | $1.833 | 1 |
| Dec 2019 | $25.00M | $25.00M - $25.00M | -$25.00M | -$1.35 | 1 |
| Dec 2018 | $17.77M | $17.77M - $17.77M | -$17.77M | -$1.497 | 1 |
| Dec 2017 | $144.18M | $144.18M - $144.18M | -$144.18M | -$0.23 | 1 |
| Dec 2016 | $6.11M | $6.11M - $6.11M | -$6.11M | -$1.41 | 1 |